Anti-Amyloid Effects of Small Molecule A&bgr;-Binding Agents in PS1/APP Mice

E-ISSN： 1875-628x|6|6|437-444

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.6, Iss.6, 2009-09, pp. : 437-444

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Construction of an Anti-IL-1&bgr; scfv and TNFRI Fusion Protein and Its Therapeutic Effect on RA Mice Model

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 12, 2013-11 ,pp. : 1048-1061

Bentham Science Publishers

Access to resources Recommend Favorite

Functional Autoradiography Shows Unaltered Cannabinoid CB1 Receptor Signalling in Hippocampus and Cortex of APP/PS1 Transgenic Mice

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 8, 2012-12 ,pp. : 1038-1044

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Structure-Based and Ligand-Based Design of IKK&bgr; Inhibitors as Anti-inflammation and Anti-cancer Agents

Current Medicinal Chemistry, Vol. 21, Iss. 34, 2014-11 ,pp. : 3893-3917

Bentham Science Publishers

Access to resources Recommend Favorite

&bgr;-Lactams as Neuroprotective Agents

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 8, Iss. 1, 2009-01 ,pp. : 28-35

Bentham Science Publishers

Access to resources Recommend Favorite

Small-molecule, tubulin-binding compounds as vascular targeting agents

By Marx Matthew A

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 769-776

Informa Healthcare

Access to resources Recommend Favorite